News | February 26, 2009

Orbital Therapy Launches ClearVue in EU

Orbital Therapy Launches ClearVue in EU

February 26, 2009 – Orbital Therapy, LLC announces the commercial introduction of ClearVue, prone position breast radiotherapy treatment table, in the European Union.

ClearVue is a carbon fiber add-on treatment table used to simulate and treat breast cancer patients in the prone position. ClearVue can be used with existing CT simulators and linear accelerators to plan and deliver radiation treatment for breast cancer patients.

ClearVue reportedly has the ability to provide unobstructed view and full access to the anatomy for precise treatment set-up and delivery. The open design allows the clinician to plan a treatment from more than two conventional angles and utilize more complex treatment techniques that are already in use with other anatomies.

Prone position breast cancer treatment is quickly gaining popularity. The prone position increases the separation of the target and uninvolved critical organs and minimizes or eliminates target motion caused by breathing. This results in the ability to deliver less dose to the surrounding organs such as lung and heart, and more precise dose to the intended target, according to Orbital Therapy.

For more information:


Related Content

Brainlab Introduces ExacTrac Dynamic at ASTRO 2018
News | Patient Positioning Radiation Therapy | October 25, 2018
Brainlab unveiled ExacTrac Dynamic at the American Society for Radiation Oncology (ASTRO) meeting, Oct. 21-24 in San...
Boston Scientific Closes Acquisition of Augmenix Inc.
News | Prostate Cancer | October 17, 2018
Boston Scientific Corp. announced the close of its acquisition of Augmenix Inc., developer of the SpaceOAR Hydrogel...
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
IBA Dosimetry Launches SmartScan Automated and Guided Beam Commissioning Solution
Technology | Quality Assurance (QA) | July 27, 2018
IBA (Ion Beam Applications S.A.) announced the market launch of its new SmartScan solution at the 60th annual American...
SpaceOAR Hydrogel Now Available in Japan
News | Patient Positioning Radiation Therapy | July 16, 2018
Augmenix K.K. announced that SpaceOAR hydrogel, a soft, implanted absorbable gel spacer is now available to all...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...
U.K.'s NICE Supports Use of Hydrogel Spacer in Prostate Cancer Treatement
News | Patient Positioning Radiation Therapy | September 08, 2017
Augmenix Inc. announced that the National Institute for Health and Care Excellence (NICE) in the U.K. has issued...